Over the past few months, we’ve shared information about who we are as a company, a few of my personal observations from the DOC, and some helpful resources we have found. Behind each post is a team dedicated to ensuring we comply with applicable regulations (a big thanks to them). Given that I had little to no knowledge about pharmaceutical regulations when I joined sanofi‐aventis U.S., I thought this might be an appropriate time to introduce Mark Gaydos, Acting Head of U.S. Regulatory Affairs Marketed Products, to give you a glimpse into the pharmaceutical industry and the rules that come along with it. Here’s what he had to say…

As noted in my ADA Alert Day post on March 21st, I wanted to update everyone on my progress of encouraging at least 22 of my coworkers to take the Diabetes Risk Test to find out if they are at risk for developing Type 2 diabetes.

In case you haven’t heard, tomorrow is the American Diabetes Association Alert Day – a one-day “wake-up” call asking the American public to take the Diabetes Risk Test to find out if they are at risk for developing Type 2 diabetes.

St. Patrick’s Day is upon us – and that could mean celebrating with more than just green shamrocks. As I mentioned in my “6 Things I Learned From You” article, the DOC has taught me that living with diabetes takes time and energy.

In November 2010, the Task Force for the National Conference on Diabetes, supported by sanofi‐aventis U.S., issued a formal “Call to Action” to tackle the diabetes epidemic.